Colorectal LLM Wiki

Browse
Home / Concepts / Sexual Function After Colorectal Surgery
Concept created 2026-08-27 · updated 2026-08-27
colorectalsexual-dysfunctionquality-of-lifeTMEpelvic-surgerysurvivorshiperectile-dysfunctionLGBTQ

Sexual Function After Colorectal Surgery

A survivorship/quality-of-life topic that has historically been under-discussed relative to its prevalence: sexual dysfunction is one of the most common long-term effects of colorectal cancer treatment and of pelvic surgery for benign disease, yet it is rarely and inadequately discussed between patients and providers, and therefore often goes untreated. Sexual dysfunction can occur after any colorectal surgery, not only rectal cancer resections — one study found no difference in sexual function, self-esteem, body image, or health-related quality of life between women who had abdominal (non-pelvic) procedures and those who underwent pelvic dissection. This page covers both female sexual dysfunction and male genitourinary/sexual dysfunction after colorectal surgery, each from its own dedicated ASCRS chapter — the two share underlying pelvic autonomic nerve anatomy but are otherwise organized as separate sections below, reflecting how differently the two chapters approach measurement and treatment.

Female sexual dysfunction

Scope of the problem

In colorectal cancer survivors, reported prevalence of postoperative sexual dysfunction in women ranges from 19% to 62%. The 2019 QoLiRECT (Quality of Life in RECTal cancer) study found pretreatment sexual activity already lower in women than men (29% vs. 41%), with both groups declining further by 1 year (25% vs. 34%). Female sex is itself independently associated with lower sexual function and enjoyment after colorectal cancer. Extent of resection and presence of a stoma both affect sexual function: women undergoing abdominoperineal resection were less sexually active and less likely to achieve arousal/orgasm than those undergoing anterior resection, and among anterior resection patients, those with a low anastomosis had worse quality-of-life/function scores than those with a high anastomosis. Stoma patients report significantly worse quality-of-life and greater sexual dysfunction than non-stoma patients, though quality of life improves substantially after stoma reversal.

Sexual dysfunction is not limited to malignant disease: pelvic floor surgery for benign conditions, and pelvic dissection for inflammatory bowel disease (IBD) specifically, can also significantly affect sexual function. In IBD, sexual dysfunction is reported in 40–60% of female patients. Women with ulcerative colitis managed nonoperatively retain normal fertility, implying UC and medical therapy themselves do not impair reproductive ability — but pelvic pouch surgery (IPAA) does significantly affect sexual function, likely via autonomic nerve injury during pelvic dissection (see Ulcerative Colitis, Total Mesorectal Excision (TME) & Sphincter-Sparing Resection).

Etiology

Multifactorial, with both physical and psychological causes that frequently coexist: 30–40% of female patients who were sexually active before treatment become sexually inactive afterward. More than half of women experience changes in body image after colorectal cancer treatment. Women specifically experience reduced lubrication, more dyspareunia, reduced vaginal size, and less sexual enjoyment after surgery compared to their pretreatment baseline.

Colonic surgery generally does not involve other major organs and is usually a one-stage procedure, carrying substantially lower risk than pelvic/rectal surgery, which involves organs in close proximity (vagina, bladder) and the pelvic autonomic nerves in a confined space, and may involve a two-stage procedure with stoma creation/closure.

Radiation

A key contributor to female sexual dysfunction, acting via damage to pelvic autonomic nerves, microvasculature, and soft tissue (acute edema/inflammation), and via the vagina and vulva's inherent radiosensitivity (rapid cell turnover). Acute effects (erythema, desquamation, mucositis, congestion) usually resolve within 3 months, but effects can be progressive and become symptomatic even after a latent period. Progressive vascular compromise and tissue hypoxia can lead to epithelial sloughing, ulceration, and eventual fibrosis — clinically manifesting as vaginal wall thinning, atrophy, adhesions, decreased elasticity, narrowing, shortening, and vaginal stenosis. Radiation- induced endarteritis obliterans can cause a hemorrhagic, fragile, friable vagina, with similar effects possible in the bladder and rectum. In premenopausal women, radiation can induce ovarian failure and permanent menopause, with severity depending on treatment field and total dose.

Multiple studies corroborate a significant negative effect: the landmark Dutch TME trial (short-course preoperative radiotherapy, 5Gy × 5) found a negative impact on sexual activity/function, with sexual activity in irradiated women declining from >50% preoperatively to 18.4% at 2 years — and this negative effect on vaginal dryness/dyspareunia persisted at 14-year follow-up compared to the general population. A Danish cross-sectional study (Bregendahl et al.) similarly found neoadjuvant radiotherapy associated with reduced vaginal dimensions, dyspareunia, lack of desire, and sexual inactivity. Radiotherapy exposure has been associated with roughly a doubling of the odds of overall sexual dysfunction (OR 1.80) in a long-term Danish population-based study (Thyø et al., n=2402). Late effects are common and persistent: in one survey, treatment-related sexual symptoms were reported as frequently by patients 6–11 years post-radiotherapy as by those 1–5 years out.

Chemotherapy

Less well studied in isolation (often bundled with radiation as neoadjuvant chemoradiation). Associated with loss of desire and decreased intercourse frequency; common side effects (nausea, vomiting, diarrhea, hair loss) can affect self-esteem and sexual self-image. In women, chemotherapy can cause loss of ovarian estrogen production, leading to decreased vaginal dimension, thinning, dryness, and loss of elasticity — producing dyspareunia and orgasmic dysfunction.

Surgery

Nerve injury is the central mechanism. An extensive autonomic network (sympathetic and parasympathetic) supplies the rectum and genitourinary tract: the sympathetic plexus arises from T12–L2, forms the superior hypogastric plexus as it enters the pelvis, and divides into the left and right hypogastric nerves at the sacral promontory — injury here causes urinary urgency and incontinence. The hypogastric nerves join parasympathetic fibers along the mesorectal fascia to form the inferior hypogastric plexus, responsible for detrusor contractility, vaginal lubrication, and genital swelling during arousal — injury here reduces vaginal blood flow and lubrication. The neurovascular bundle extends anterolaterally from this plexus toward the distal ureters, cervix, vaginal fornix, bladder base, and lower lateral vaginal wall — all at risk during pelvic dissection.

Total mesorectal excision (TME) (see Total Mesorectal Excision (TME) & Sphincter-Sparing Resection) is by definition a nerve-preserving dissection along the avascular mesorectal-fascia/parietal-pelvic-fascia plane, and its standardization has reduced accidental bladder denervation from 50–60% down to under 20% — though the corresponding reduction in sexual dysfunction specifically is less well described (most denervation-outcome data, including the ED/ejaculatory-dysfunction figures on Total Mesorectal Excision (TME) & Sphincter-Sparing Resection and General Postoperative Complications, comes from male patients). No clear difference in bladder or sexual quality-of-life outcomes has been shown between laparoscopic and open TME; a robotic approach has been reported to lower urinary/sexual impairment, but again the evidence base is predominantly male.

Fertility

Distinct from (but related to) sexual dysfunction. Colon cancer resection likely has no effect on female fertility, but resection below the peritoneal reflection for rectal cancer may impair fertility via autonomic nerve injury. IPAA for IBD/polyposis syndromes (e.g. Lynch syndrome) is associated with reported fertility reductions of 44–82%; a laparoscopic approach appears to improve fertility versus open surgery, likely via reduced fallopian tube scarring. IBD surgery may also worsen pregnancy-related outcomes (miscarriage, need for assisted reproduction, cesarean delivery, stillbirth/preterm birth), though evidence quality is mixed; whether cesarean section is needed post-IPAA specifically to protect the anal sphincter remains controversial (see Ulcerative Colitis). 5-fluorouracil chemotherapy has little known effect on fertility; the gonadal-failure impact of oxaliplatin/irinotecan is unclear. Radiation (adjuvant or neoadjuvant) may cause premature ovarian failure at current dosing; fertility-preservation options include ovarian transposition and embryo cryopreservation (established), with ovarian tissue cryopreservation and ovarian suppression still investigational.

The four phases of female sexual response, and dysfunction by phase

Normal female sexual response: desire → arousal → orgasm → resolution. Sexual dysfunction is correspondingly categorized as desire, arousal, orgasmic, and sexual pain disorders. As many as 1 in 5 women who receive pelvic radiotherapy report sexual pain specifically, often while still reporting continued desire for intercourse — underscoring that pain and desire loss are distinct problems requiring different treatment approaches.

  • Desire: treatment-induced menopause/hypogonadism → hormone replacement therapy (estrogen and/or testosterone), oncological contraindications permitting. Where desire loss instead reflects emotional adjustment or medication side effects → psychological/psychosexual counseling, cognitive behavioral therapy, or mindfulness training, alone or combined with pharmacologic/device interventions.
  • Arousal and orgasm: most treatment research is male-focused (erectile dysfunction as the primary outcome), so female arousal/orgasm treatment is often grouped with desire treatment — hormone replacement for desire, psychological/psychosexual/cognitive behavioral therapy for both.
  • Sexual pain: proactive management of radiation- and menopause-induced vaginal changes is not part of routine post-colorectal-surgery care, and post-radiotherapy vaginal dilation regimens are frequently disrupted by surgery, with poor coordination of multimodal late-effects management. For superficial dyspareunia from treatment-induced menopause: hormone replacement therapy, or vaginal estrogens where feasible; nonhormonal vaginal moisturizers when estrogen is contraindicated or postmenopausal; intimate lubricants during intercourse. For deep dyspareunia from adhesions/fibrosis/stenosis/shortening: graduated vaginal dilation within a sensate-focus framework, though the evidence base and patient compliance for dilation are both poor. Chronic pelvic floor myofascial pain is an increasingly recognized sequela of colorectal surgery/adjuvant treatment that can worsen dyspareunia — a standardized physical exam and multidisciplinary treatment (myofascial trigger point release, biofeedback, electrical stimulation) can help diagnose and treat it.

Measurement (female)

Validated patient-reported instruments are essential given how heavily this area relies on self-report. The Pelvic Floor Disorders Consortium (PFDC) Working Group on Patient Reported Outcomes (a cross-disciplinary collaboration including ASCRS members) reviewed available instruments and recommends two for best practice:

  • Female Sexual Function Index Short Version (FSFI-9) — a 9-item questionnaire covering desire, arousal, lubrication, orgasm, satisfaction, and pain domains; best applied when sexual function is a secondary endpoint and brevity is a priority. Well-validated in peri- and postmenopausal women.
  • Pelvic Organ Prolapse/Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR) — a 20-item condition-specific questionnaire (12 questions across 4 domains if not sexually active) targeting women with pelvic floor disorders specifically; PFDC's recommendation for providers treating known pelvic floor disorder patients, versus FSFI-9 for general screening outside that population.

Initiating the conversation

Despite ~80% of surveyed cancer patients (via the PROMIS Sexual Function measure) reporting that discussing surgery/cancer's impact on sexual function is important, only 29% were actually asked about sexual dysfunction, and fewer than half of those received any related information from their provider. Barriers reported by patients: embarrassment, uncertainty how to broach the subject, and a sense that providers seemed too busy or did not prioritize the topic relative to cancer/surgical outcomes. Barriers reported by providers: lack of clinical time (follow-up visits prioritizing cancer surveillance), lack of privacy, absence of clear management/referral pathways, and lack of knowledge about how to start the conversation or what treatments to offer. Patients consistently report feeling more comfortable discussing sexual dysfunction when the provider raises the topic first, rather than waiting to be asked.

Cultural factors (age, ethnicity, sexual orientation, relationship status) significantly influence sexuality but are often neglected in both research and clinical practice; assumptions that sexual function is "irrelevant" for elderly or LGBTQ patients are explicitly flagged as incorrect and harmful to address openly.

Multidisciplinary treatment team (female)

Given the range of physical, psychological, and hormonal contributors, effective management typically requires a team beyond the colorectal surgeon alone: psychologist/psychiatrist or other counselor, sex therapist, pelvic floor physical therapist, oncologist, radiation oncologist, geriatrician, nutritionist, and exercise physiotherapist, tailored to individual patient needs.

Male genitourinary dysfunction

Studies estimate the prevalence of male genitourinary dysfunction after pelvic colon and rectal procedures at 20–80%. Pelvic autonomic nerve dysfunction is a complication of many common colon and rectal procedures, driven by direct surgical nerve injury, adjunctive pelvic radiotherapy or systemic chemotherapy, or the psychological impact of long-term fecal diversion. As with the female literature, patients and providers alike report difficulty discussing genitourinary function due to embarrassment; detailed provider knowledge of the anatomy and treatment landscape can reduce both provider and patient discomfort with the conversation.

Neuroanatomy and physiology

The same pelvic autonomic network described above for women drives male genitourinary function, with sex-specific downstream effects:

  • Sympathetic innervation originates from T12–L2, forming the superior hypogastric plexus around the distal aorta/aortic bifurcation, which coalesces into the bilateral hypogastric nerves at the sacral promontory. These course laterally around the rectum and join the nervi erigentes to form the inferior hypogastric plexus at the anterior peritoneal reflection, then pass anterior to Denonvilliers' fascia to supply the genitourinary system. Sympathetic outflow predominantly regulates ejaculation (and, to a lesser degree, penile erection). Ejaculation has two phases: expulsion (sympathetically-mediated movement of seminal fluid into the prostatic urethra) and emission (somatically-mediated penile muscle contraction expelling the fluid). Damage to sympathetic inflow predominantly causes retrograde ejaculation; aberrant sympathetic bladder innervation causes bladder atonia with urinary retention/overflow incontinence.
  • Parasympathetic innervation originates from S2–S4 (predominantly S3), forming the pelvic splanchnic nerves/nervi erigentes that ascend to join the inferior hypogastric plexus, which then courses deep to Denonvilliers' fascia at the level of the prostate to supply the seminal vesicles/prostate and posterior bladder. Parasympathetic innervation regulates erectile function via vasodilation/engorgement of the penile vascular sinuses — injury to the nervi erigentes or inferior hypogastric plexus predominantly causes male impotence, and (given the plexus's mixed fiber content) can also cause retrograde ejaculation. The "micturition center" lies within S2–S4 and is highly centrally regulated; damage to parasympathetic bladder pathways causes detrusor-sphincter dyssynergia and functional bladder outlet obstruction.

Measurement (male)

The Pelvic Floor Disorders Consortium's multispecialty effort (colorectal surgeons, urogynecologists, urologists, gynecologists, gastroenterologists, physical therapists) has worked to standardize male genitourinary metrics, since many available instruments are narrowly specialty-specific or too unwieldy for routine clinical use.

Sexual dysfunction metrics: the consortium recommends the International Index of Erectile Function (IIEF-15), the most-cited instrument for male sexual function, with five separately validated domains (erectile function, orgasmic/ejaculatory function, sexual desire, intercourse satisfaction, overall satisfaction) and validation in 10 languages. The abbreviated IIEF-5 (SHIM, Sexual Health Inventory for Men) uses 5 of the IIEF's items (erectile function domain plus one intercourse-satisfaction item) and is brief and widely cited, though it omits the orgasmic/ejaculatory, desire, and overall-satisfaction domains. The Expanded Prostate Cancer Index Composite (EPIC) is a thorough 50-question, 4-domain (urinary, bowel, sexual, hormonal) instrument validated only in prostate cancer patients — comprehensive but impractical for routine use.

Urinary dysfunction metrics: the Urogenital Distress Inventory (UDI/UDI-6) was validated primarily in women but is also used in men (English-speaking populations only). The King's Health Questionnaire is validated in both sexes and available in multiple languages, examining 10 urinary-symptom-related quality-of-life factors. The Danish Prostatic Symptom Score assesses distress from 12 urinary symptoms. The International Continence Society (ICS) male questionnaire (and its abbreviated form) scores 20 urinary symptoms across a voiding subscore and an incontinence subscore.

Colorectal procedures and genitourinary dysfunction risk

Risk increases as dissection proceeds lower into the confined pelvis. At the level of the sigmoid and upper mesorectum, the superior hypogastric plexus and hypogastric nerves are typically apparent and easy to preserve, so genitourinary dysfunction after a straightforward anterior resection (not entering the deep pelvis) is limited. As dissection progresses into the mid/upper rectum, injury risk to the inferior hypogastric plexus and nervi erigentes rises as anatomy becomes less apparent in the narrow workspace; staying superficial to Denonvilliers' fascia when mobilizing the anterolateral rectum minimizes (but does not eliminate) dysfunction. Abdominoperineal resection carries the highest risk, multifactorially — autonomic nerve damage, disrupted pelvic floor anatomy/function, and the psychological impact of a major body-image change (permanent stoma). Dysfunction also tends to be more common after oncologic than non-oncologic pelvic surgery, though some literature is contradictory.

Data on minimally invasive vs. open TME is limited and controversial: the magnified view of MIS proctectomy facilitates sharp dissection around autonomic-nerve-bearing spaces, but published comparisons of laparoscopic/robotic vs. open (and of robotic vs. laparoscopic) approaches for postoperative male sexual function are small, single-center, retrospective, and give variable results.

Pelvic radiotherapy is a common contributor to erectile dysfunction and infertility, and also causes urinary dysfunction (urgency, incontinence, radiation cystitis, ureteral/urethral stricture, fistula) via multifactorial mechanisms; systemic chemotherapy has a detrimental but lesser effect than radiotherapy or surgery.

Management of male genitourinary dysfunction

A stepped approach, starting with the least invasive options:

  • Vacuum constriction device (VCD/"penis pump") — oldest, cheapest, lowest-risk option (mainly penile-base bruising); patient satisfaction 50–80%. Common complaints: interruption of intimacy to apply the device, unnatural erection sensation, blocked ejaculation, anorgasmia.
  • Intracorporeal (IC) injections — vasoactive drugs (alprostadil alone, or combinations like Bimix [papaverine/phentolamine] or Trimix [alprostadil/phentolamine/papaverine]) injected directly into the corpora; remains effective for neurogenic ED after pelvic surgery even in the oral-therapy era. Successful erection in ~90%, satisfaction ~80%, but 30–70% discontinue over time; complications include injection-site pain, hematoma, fibrosis, and priapism, with combination agents more effective but more complication-prone than alprostadil alone.
  • Intraurethral alprostadil — avoids injection but has a lower success rate (~60%) with a more favorable complication profile (mainly penile pain/mild urethral bleeding); wider patient acceptance than IC injections.
  • Oral PDE5 inhibitors — well recognized due to direct-to-consumer marketing; require intact neurologic impulses to work, making them less effective for the neurogenic impotence typical after pelvic surgery.
  • Penile prosthesis — for medical-therapy failures. Inflatable prosthesis gives the most natural erection/deflation but is more complex with higher malfunction/revision rates and requires dexterity to operate; semirigid rod is simpler to use but leaves a permanent semi-rigid state, difficult to conceal. Both carry infection/erosion risk requiring explantation, and penile fibrosis/scarring can impair length and device efficacy.
  • Retrograde ejaculation / anejaculation — a "dry orgasm" from failure of urethral sphincter closure, sending ejaculate into the bladder; not harmful and orgasm sensation is preserved, but causes infertility. Does not typically respond to medical therapy (e.g. pseudoephedrine). For patients wanting to father children, semen can be harvested from voided urine, washed, and used with assisted fertilization techniques.
  • Urinary retention — short-term: indwelling catheter decompression plus alpha-blockade. Persistent retention: chronic intermittent (self-)catheterization after office teaching; long-term indwelling or suprapubic catheter for patients with non-recoverable bladder function or unable to self-catheterize.

Psychological impact and counseling

Establishing rapport for frank preoperative discussion of intimate matters is the first step. A thorough preoperative functional history predicts postoperative risk, and informed consent should explicitly cover the potential types of genitourinary dysfunction. Postoperatively, active questioning (rather than waiting for patients to volunteer symptoms), acknowledgment that a problem exists, and reassurance that function often improves with time are all valuable; early discussion of treatment pathways reduces anxiety, and an early referral relationship with a urologist interested in male genitourinary dysfunction supports long-term rehabilitation.

LGBTQ populations

Sexual function in LGBTQ populations after pelvic surgery is "regrettably unexplored and poorly understood," with most available data coming from urology/prostatectomy literature rather than colorectal surgery specifically — despite over 30% of the general population regarding the anus and rectum as sexual organs. Gay and bisexual men (GBM) undergoing treatment that threatens genitourinary function report the same confidence/identity issues as heterosexual men, but with additional layers: greater mental health burden and less emotional/social/partner support post-treatment than heterosexual men, an elevated risk of mood/anxiety disorders and suicidal ideation (compounded by discrimination), and functional consequences specific to anal-receptive intercourse — some couples shift from a receptive to an insertive role after surgery, a change with implications well beyond positioning (affecting initiation dynamics, relationship affection patterns, and sexual identity). Anodyspareunia (pain with receptive anal intercourse) is a recognized, clinically-defined consequence of anorectal/pelvic surgery in GBM: among patients meeting diagnostic criteria, 82% had avoided anal sex for a period, 49% restricted themselves to an insertive-only role, 31% reported relationship disruption, and 15% reported inability to form new sexual partnerships. A dedicated instrument, the Gay Sexual Functioning Inventory (Rosser et al. 2019, developed from the Restore Study), is the first tool quantifying sexual/urinary problems and quality-of-life impact specifically in GBM treated for prostate cancer — not yet validated in a colorectal-surgery population.

Distinct from the nerve-injury mechanisms above: a permanent stoma carries its own psychological impact on sexual function, independent of bowel function itself. Validated ostomate quality-of-life metrics show near-universal alterations in body image, lifestyle changes attributable to the stoma (80%), and impaired sexuality (40%); studies comparing ostomates to non-ostomates generally show better quality of life for non-ostomates regardless of underlying bowel function, and an increased suicide risk has been documented in ostomates.

Open items / gaps

  • No wiki-independent primary trial data yet for any female or male treatment option described above (hormone replacement, vaginal dilation, psychosexual therapy, VCD, IC injections, oral PDE5 inhibitors, penile prosthesis) — all reported as extracted from the two ASCRS chapters' secondary summaries of the underlying literature. Both chapters explicitly call for larger-scale controlled trials, particularly in women (where treatment evidence is often extrapolated from male-focused arousal/orgasm research) and in LGBTQ populations (where colorectal-specific data is essentially absent).
  • The Gay Sexual Functioning Inventory has only been validated in a prostate-cancer (urology) population, not yet in colorectal surgery patients — an explicit evidence gap noted in Ch64 itself.
  • No APR-specific (vs. general proctectomy) quantified sexual/genitourinary dysfunction rate is available on this page — see the related open item on Abdominoperineal Resection (APR) and General Postoperative Complications.